Showing results (61-70 of 87) with videos related to
Sort By:
Pageof 9
Cancer Science|March 22, 2023
A gain-of-function mutation in microRNA 142 is sufficient to cause the development of T-cell leukemia in miceShingo Kawano, Kimi Araki, Jie Bai, et al.The EMBO Journal|May 29, 2024
Chromatin modifier Hmga2 promotes adult hematopoietic stem cell function and blood regeneration in stress conditionsSho Kubota, Yuqi Sun, Mariko Morii, et al.Cell Stem Cell|January 9, 2009
p53 regulates hematopoietic stem cell quiescenceYan Liu, Shannon E Elf, Yasuhiko Miyata, et al.The Journal of Experimental Medicine|April 18, 2023
Exposure to microbial products followed by loss of Tet2 promotes myelodysplastic syndrome via remodeling HSCsTakako Yokomizo-Nakano, Ai Hamashima, Sho Kubota, et al.Leukemia|September 9, 2021
Insufficiency of non-canonical PRC1 synergizes with JAK2V617F in the development of myelofibrosisDaisuke Shinoda, Yaeko Nakajima-Takagi, Motohiko Oshima, et al.The Journal of Clinical Investigation|August 7, 2018
Ezh2 loss propagates hypermethylation at T cell differentiation-regulating genes to promote leukemic transformationChangshan Wang, Motohiko Oshima, Daisuke Sato, et al.Cancer Research|April 29, 2020
Overexpression of RUNX3 Represses RUNX1 to Drive Transformation of Myelodysplastic SyndromeTakako Yokomizo-Nakano, Sho Kubota, Jie Bai, et al.Oncogene|April 3, 2026
Trisomy 8 alters chromatin conformations and activates Y chromosome genes in stem cells to drive a pre-leukemic stateJie Bai, Kimi Araki, Daisuke Kurotaki, et al.Nature Communications|August 30, 2019
Author Correction: Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasmSho Kubota, Kenji Tokunaga, Tomohiro Umezu, et al.Nature Communications|April 12, 2019
Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasmSho Kubota, Kenji Tokunaga, Tomohiro Umezu, et al.Pageof 9